Zobrazeno 1 - 9
of 9
pro vyhledávání: '"van den Eertwegh Alfons JM"'
Autor:
Revicki Dennis A, van den Eertwegh Alfons JM, Lorigan Paul, Lebbe Celeste, Linette Gerald, Ottensmeier Christian H, Safikhani Shima, Messina Marianne, Hoos Axel, Wagner Samuel, Kotapati Srividya
Publikováno v:
Health and Quality of Life Outcomes, Vol 10, Iss 1, p 66 (2012)
Abstract Background In an international, randomized Phase III trial ipilimumab demonstrated a significant overall survival benefit in previously treated advanced melanoma patients. This report summarizes health-related quality of life (HRQL) outcomes
Externí odkaz:
https://doaj.org/article/4626a5700027429b89a5abe3cdc564a2
Autor:
van den Eertwegh, Alfons JM, Versluis, Jurjen, van den Berg, H Pieter, Santegoets, Saskia JAM, van Moorselaar, R Jeroen A, van der Sluis, Tim M, Gall, Helen E, Harding, Thomas C, Jooss, Karin, Lowy, Israel, Pinedo, Herbert M, Scheper, Rik J, Stam, Anita GM, von Blomberg, B Mary E, de Gruijl, Tanja D, Hege, Kristen, Sacks, Natalie, Gerritsen, Winald R
Publikováno v:
In Lancet Oncology May 2012 13(5):509-517
Autor:
De Remigis, Alessandra, de Gruijl, Tanja D, Uram, Jennifer N, Tzou, Schey-Cherng, Iwama, Shintaro, Talor, Monica V, Armstrong, Todd D, Santegoets, Saskia J A M, Slovin, Susan F, Zheng, Lei, Laheru, Daniel A, Jaffee, Elizabeth M, Gerritsen, Winald R, van den Eertwegh, Alfons JM, Le, Dung T, Caturegli, Patrizio
Cancer immunotherapy induces a variety of autoinflammatory responses, including those against the thyroid gland, which can be exploited to predict clinical outcomes. Considering the paucity of information about thyroid autoimmunity in patients receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::116e25a6df4436fccb7e10f9184f9097
https://europepmc.org/articles/PMC4199892/
https://europepmc.org/articles/PMC4199892/
Autor:
Lindenberg, Jelle J, van de Ven, Rieneke, Oosterhoff, Dinja, Sombroek, Claudia C, Lougheed, Sinéad M, Stam, Anita GM, Koenen, Hans JPM, van den Eertwegh, Alfons JM, Scheper, Rik J, de Gruijl, Tanja D
Publikováno v:
Human Vaccines & Immunotherapeutics; June 2014, Vol. 10 Issue: 6 p1622-1632, 11p
Autor:
van der Vliet, Hans JJ, Pinedo, Herbert M, von Blomberg, B Mary E, van den Eertwegh, Alfons JM, Scheper, Rik J, Giaccone, Giuseppe
Publikováno v:
In Lancet Oncology 2002 3(9):574-574
Publikováno v:
In Lancet Oncology 2000 1(2):72-73
Autor:
Santegoets, Saskia Jam, Turksma, Annelies W, Suhoski, Megan M, Stam, Anita Gm, Albelda, Steve M, Hooijberg, Erik, Scheper, Rik J, van den Eertwegh, Alfons Jm, Gerritsen, Winald R, Powell Jr, Daniel J, June, Carl H, de Gruijl, Tanja D, Santegoets, Saskia J A M, Stam, Anita G M, van den Eertwegh, Alfons J M, Powell, Daniel J Jr
Publikováno v:
Journal of Translational Medicine; 2013, Vol. 11 Issue 1, p37-37, 1p
Autor:
Koster BD; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., López González M; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Hout MF; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Turksma AW; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Sluijter BJ; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Molenkamp BG; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Leeuwen PA; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vosslamber S; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Scheper RJ; Department of Pathology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Eertwegh AJ; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Tol MP; Department of Surgical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jordanova EJ; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands td.degruijl@amsterdamumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Autor:
Santegoets SJ; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Stam AG; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands ; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Lougheed SM; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Gall H; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jooss K; Cell Genesys Inc, South San Francisco, CA USA., Sacks N; Cell Genesys Inc, South San Francisco, CA USA., Hege K; Cell Genesys Inc, South San Francisco, CA USA., Lowy I; Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company, Wallingford, CT USA., Scheper RJ; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Gerritsen WR; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., van den Eertwegh AJ; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2014 Sep 16; Vol. 2, pp. 31. Date of Electronic Publication: 2014 Sep 16 (Print Publication: 2014).